Event

Events

PhRMA hosts online and in-person events exploring science and policy issues that impact biopharmaceutical innovation and patient access to medicines. With members from the nation’s leading biopharmaceutical research companies, our events offer unique insights about the future of health in America.

+Share This

Share This

Mar 17, 2021

The Lessons of a Pandemic

PhRMA sponsored the Washington Post Live event: The Lessons of a Pandemic. The event was hosted by Paige Winfield Cunningham, and focused on various lessons learned over the course of the COVID-19 pandemic. Those lessons included vaccinating children, vaccine research and hesitancy, new CDC guidance, and the biopharmaceutical industry’s work to combat the pandemic.

learn more

Nov 19, 2020

The 2020 STAT Summit: What’s Next?

The coronavirus pandemic continues to reshape our country and the world, particularly when it comes to challenging the perception of “what’s possible” in biopharmaceutical innovation. PhRMA recently sponsored STAT News' 2020 health summit convening leading health care CEOs, researchers, thought leaders, policymakers, physicians and health policy experts.

learn more

Aug 18, 2020

Bloomberg Prognosis: How Covid-19 is Reshaping the Global Healthcare Ecosystem

PhRMA and Bloomberg recently hosted a virtual event to discuss how the ongoing COVID-19 crisis continues to shape the evolution of the clinical and research ecosystem and what we will need to combat future health care challenges.

learn more

Jul 9, 2020

Health Reimagined: The Future of Healthcare

On July 9, 2020, The Hill gathered public health officials, policymakers and leaders from across the healthcare ecosystem to dive into the biggest medical and healthcare trends and innovations, considering both longitudinal trends and their interplay with the recent global health pandemic.

learn more

Jul 9, 2020

Bridging the Gap: New Collaborations to Drive Antimicrobial Innovation

This virtual event launched the AMR Action Fund, a partnership that aims to bring 2-4 new antibiotics to patients by 2030. These treatments are urgently needed to address the rapid rise of antibiotic-resistant infections – also called antimicrobial resistance, or AMR. The fund will invest approximately $1 billion to ensure a robust and diverse pipeline of new medicines to treat drug-resistant infections.

Learn More

Jun 16, 2020

Six Months Into The COVID-19 Pandemic: Where Are We Now?

An on-the-record briefing about where the biopharmaceutical industry is in the process of researching and developing potential treatments, vaccines and diagnostics for COVID-19.

learn more

May 28, 2020

COVID-19: Bending the Curve

As part of a livestreamed three-part series, McClatchy is bringing together top-rated medical professionals, industry experts, patient advocates and policymakers to discuss the latest advancements to combat the virus. The first event’s focus will be innovation and treatment; McClatchy will explore from three perspectives how our country can accelerate research and innovation toward treatments for patients suffering from COVID-19. The following installments will focus on the path to a vaccine and the long-term impact of this crisis on health care policy.

Learn More

Apr 14, 2020

COVID-19: On the Front Lines

For this online event, The Atlantic convened experts fighting COVID-19 on the front lines—doctors, public health officials and pharmaceutical executives. They shared their latest insights, news about potential treatments and what the immediate future holds.

Learn More

Apr 8, 2020

Combatting COVID-19

The pandemic caused by the novel coronavirus has shut down countries around the world. STAT held a three-part digital event series that brought together experts to discuss one of society’s biggest hopes – that treatments or even vaccines can be developed. The audience was joined by executives from companies leading the way in developing treatments and they discussed current findings, clinical trials and efforts to expedite approvals as we face this global pandemic.

Learn More

Jul 25, 2019

Innovation Day 2019

PhRMA Innovation Day convened over 175 digital health stakeholders, including member company R&D, regulatory, and digital leadership alongside patient groups, investors, key opinion drivers, and policy makers to chart the potential for the digitalization of the healthcare ecosystem.

learn more

May 8, 2019

The State of Care: Future of Medicare

Baby Boomers face rising medical costs. At the same time, Medicare is growing, and taking up a greater share of the federal budget. While the Trump administration and Congress consider changes to Medicare, how can we keep costs in line, while also giving older Americans the care they need? The Atlantic gathered government officials, healthcare experts, and patient advocates to discuss the path forward for Medicare.

learn More

May 1, 2019

How Women are Leading Medical Innovation

From 1990 to 2016, the share of women in the life sciences industry increased from 34 to 47 percent. Women also make up more than half of Ph.Ds. in biological and agricultural sciences. And many researchers are working to address health issues affecting women, ranging from endometriosis to heart conditions. Industry leaders, policymakers and academics have also shown how they’re dedicated to continuing to support innovation — and this includes fostering the next generation of scientists.

learn More

Nov 28, 2018

Forbes Healthcare Summit

Medicine is improving at a breakneck pace; breakthroughs such as immunotherapy and genetics are changing the way we treat cancer. New drugs are being approved at an unprecedented rate while artificial intelligence and deep learning, until recently just science fiction, are actually starting to make a real difference in public health. The big question now: how can we take this kindling and set it ablaze?

Learn More

Nov 14, 2018

People v. Cancer

Cancer isn’t as lethal as it once was, and yet more than 600,000 Americans are estimated to die from it this year alone, making this complex set of diseases the second leading cause of death in the country. But hope is rising: big data, immuno-oncology and once-in-a-generation medical advances have led to dramatic breakthroughs. New insights into the disease have pushed boundaries, with patients receiving uniquely personalized care.

learn More

Oct 3, 2018

Leading on Value: Solutions for an Evolving Health Care System

How can Washington and the private sector work together to manage the cost of health care and deliver value to consumers? The two-part event will feature health care industry CEOs discussing the evolution of the pharmaceutical business model and a reevaluation of priorities including production of personalized medicines, R&D, and care for chronic diseases.

learn more

Sep 17, 2018

Turning Point: Documentary Screening + Conversation

An estimated 5.7 million people in this country have Alzheimer’s. And the search for a treatment or a cure has not been promising. In the documentary, Turning Point, filmmaker James Keach, follows a team of scientists on the front lines of Alzheimer’s research and captures the disappointment and renewed hope of those working to disrupt the disease.

learn More

Sep 12, 2018

The State of Care: Disrupting Alzheimer's

The history of Alzheimer’s research has been filled with setback after setback – in fact nearly every clinical trial has failed – but it is also one marked by perseverance and renewed hope. Advancements in medical imaging have increased our understanding of how the disease strikes, and efforts are underway to develop diagnostics to treat the disease before its onset.

learn More

Jul 17, 2018

The State of Care: Innovation & Access

America is a laboratory for ideas – a testing ground to advance human thought and potential from which entire industries have been born – from media and entertainment, to tech giants capitalizing on the great internet awakening, to scientific discoveries and life-saving cures.

learn more

May 23, 2018

The State of Care Patient Access and Affordability

The Atlantic gathered key perspectives to continue the conversation on what it costs to stay healthy in America today.

learn More

May 3, 2018

Deconstructing the Prescription Drug Supply Chain

PhRMA and POLITICO joined together for a deep-dive conversation on the state of the pharmaceutical supply chain and what can be done to better control costs.

Learn More